Browse the corpus

Epinephrine, a widely used medication and hormone, is critical in managing various medical conditions due to its potent action on the sympathetic nervous system. Epinephrine is approved by the US Food and Drug Administration (FDA) for treating type 1 hypersensitivity reactions (including anaphylaxis), managing hypotension from septic shock, and inducing mydriasis during intraocular surgeries. Epinephrine exerts its effects through α- and β-adrenergic receptors with dose-dependent actions as a sympathomimetic catecholamine. Low doses primarily activate β-receptors, enhancing bronchodilation and cardiac activity, while higher doses engage α-receptors to induce vasoconstriction and increase vascular tone. Adverse effects of the drug include tachycardia, hypertension, headache, anxiety, and tremors. This activity highlights the indications, mechanism of action, adverse event profile, pharmacology, and relevant interactions of epinephrine, emphasizing the importance of understanding prescribing parameters due to its long-standing use in clinical practice. This activity aims to optimize patient care by providing evidence-based knowledge on the safe and effective use of epinephrine, focusing on strategies to minimize risks and adverse reactions while maximizing therapeutic benefits. In addition, this activity emphasizes the role of interprofessional healthcare team members in managing conditions requiring epinephrine by providing them with the skills to deliver personalized, safe, and effective care, thereby enhancing patient safety and outcomes during its administration. Objectives: Identify the indications for epinephrine use in anaphylaxis, septic shock, and intraocular surgeries. Implement safe administration practices to minimize the adverse effects of epinephrine, including accurate dosing and monitoring. Select the correct epinephrine dose and route of administration for various clinical scenarios. Collaborate with interprofessional healthcare team members to manage emergencies requiring epinephrine, ensuring timely and effective care. Access free multiple choice questions on this topic.

Signs and Symptoms of Overdose Epinephrine overdose may lead to myocardial ischemia, infarction, renal insufficiency, and cardiomyopathy. Patients may also experience severe pallor, cold skin, and metabolic acidosis due to elevated blood lactic acid levels. These complications are more likely in individuals with preexisting conditions or when epinephrine is administered in high doses. Pulmonary edema may also occur as a result of peripheral vasoconstriction and myocardial stimulation.[30] Due to its strong β1-adrenergic effects on cardiac tissue, epinephrine toxicity can result in potentially fatal cardiac arrhythmias or ischemia. Epinephrine toxicity may also lead to fatal dysrhythmias, cardiac arrest, and significant cardiac morbidity. Case reports have also associated epinephrine toxicity with Takotsubo cardiomyopathy.[31] Management of Overdose Excessive epinephrine administration, leading to supra-therapeutic levels, may cause predictable adverse effects requiring supportive treatment. An α-adrenergic blocker or vasodilators such as nitrites may be used to minimize pressor effects. Respiratory support and an α-adrenergic blocking agent might be necessary to reduce vasoconstriction and improve vascular flow. For potentially fatal cardiac arrhythmias or ischemia, β-adrenergic blocking agents should be administered.

Although numerous medications are readily available for various medical conditions in both inpatient and outpatient settings, epinephrine is not often discussed until a patient experiences severe medical deterioration. Due to its physiological effects, epinephrine is commonly used in "code" situations, such as ventricular fibrillation and pulseless electrical activity. These situations demand the expertise and collaboration of an interprofessional healthcare team, including physicians, nurses, pharmacists, emergency medical technicians (EMTs), and other healthcare professionals. During such critical circumstances, the team leader—usually the attending physician—oversees and makes medical decisions. The clinician, supported by other healthcare professionals and students, interprets electrocardiography (ECG) findings and determines when epinephrine is necessary. From an EMT perspective, epinephrine is usually pre-prepared for immediate administration in prehospital settings, allowing for rapid intervention. In contrast, hospital-based providers may need to draw epinephrine from a vial using a syringe, which can introduce time delays. Effective interprofessional communication is crucial in these critical situations to ensure all healthcare team members are informed and aligned on the necessary steps for timely and accurate administration, optimizing patient resuscitation outcomes. The proper medication dosage must be administered within an appropriate timeframe to minimize the risk of toxicity. Thus, a pharmaceutical consultation is recommended in these cases. Effective communication among all healthcare team members is essential, as everyone functions as part of an interprofessional team rather than as individuals working in isolation. Recently, researchers conducted a randomized, double-blind trial in the United Kingdom, with the primary end point being the survival rate at 30 days for out-of-hospital cardiac arrests. Secondary outcomes focused on survival rates until hospital discharge with favorable neurological outcomes.

The proper medication dosage must be administered within an appropriate timeframe to minimize the risk of toxicity. Thus, a pharmaceutical consultation is recommended in these cases. Effective communication among all healthcare team members is essential, as everyone functions as part of an interprofessional team rather than as individuals working in isolation. Recently, researchers conducted a randomized, double-blind trial in the United Kingdom, with the primary end point being the survival rate at 30 days for out-of-hospital cardiac arrests. Secondary outcomes focused on survival rates until hospital discharge with favorable neurological outcomes. The study included over 8000 patients, with roughly half receiving parenteral epinephrine or a saline placebo, along with standard care. The results indicated that epinephrine was associated with a higher 30-day survival rate compared to saline (placebo). However, there was no improvement in neurological outcomes.[32] The ACAAI recommends that clinicians counsel patients at high risk for anaphylaxis always to carry a self-injectable epinephrine device and ensure that patients are adequately educated on its indications and correct use.[6] An interprofessional approach to managing epinephrine therapy leads to the best patient outcomes with the fewest adverse effects. Effective communication and collaboration among clinicians, pharmacists, and nurses are essential to minimizing potential adverse effects and enhancing patient outcomes related to epinephrine use.